Top UK Court Invalidates Regeneron's Lab Mice Patents

Law360, London (June 24, 2020, 10:20 AM BST) -- The U.K.'s highest court has invalidated two of Regeneron's patents for genetically modifying research mice, ruling on Wednesday that patents must include enough detail for someone else to reproduce the full range of inventions that the patent would cover. 

The court has said the biotech giant did not provide enough information on the invention and that the principle of sufficiency should not be "disregarded or watered down." (AP) In a 4-1 split, the Supreme Court panel overturned a 2018 Court of Appeal ruling upholding the patents in the closely watched case. The court concluded that the American biotech giant did not provide...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!